A patient who is to undergo radionuclide therapy for an abdominal malignant effusion is prepared for
A) an IV injection of 32P-sodium chloride.
B) an IV injection of 32P-chromic phosphate.
C) an abdominal instillation of 32P-sodium chloride.
D) an abdominal instillation of 32P-chromic phosphate.
Correct Answer:
Verified
Q16: Rituximab (Rituxan) is administered as a(n)
A)bolus IV
Q17: Patient preparation for a 99mTc-depreotide study includes
A)hydration
Q18: Meta-iodobenzylguanidine (MIBG) acts as an analog to
A)glucagon.
B)neuroepinephrine.
C)calcium.
D)somatostatin.
Q19: For optimal targeting and minimal blood pool
Q20: The radiopharmaceutical used to gather additional diagnostic
Q22: Once 99mTc-sulfur colloid is administered as a
Q23: Which organ is the most common site
Q24: In selective internal radiation therapy (SIRT), 90Y
Q25: Which is NOT a radionuclide used for
Q26: A patient has polycythemia vera; the technologist
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents